Search - tctmd.com

Displaying 101 - 120 of 1248

Sort: Relevancy | Date

Presentation TCT 2024

TCT 53: Near-Infrared Spectroscopy and Intravascular Ultrasound-Guided vs. Angiography-Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The NIRVUS Trial

Presenter: Manijeh Noori

October 28, 2024

Presentation TCT 2024

TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study)

Presenter: Oskar Angerås

October 27, 2024

Presentation TCT 2024

TCT 192: Beta-Blocker Efficacy in Acute Myocardial Infarction: A Machine Learning Approach Using the KAMIR-NIH Dataset

Presenter: Woo Jin Ahn

October 27, 2024

Presentation TCT 2024

TCT 991: Ticagrelor Versus Clopidogrel in Cancer Patients With Acute Myocardial Infarction

Presenter: Andres Cordova Sanchez

October 27, 2024

News Conference News ESC 2024

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

News Features

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

Caitlin E. Cox

June 14, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Presentation ACC 2024

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Presenter: Javed Butler

April 06, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation Miami Valves 2024

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Presenter: Miguel Martillo Correa

February 03, 2024

Advertisement

TCT 53: Near-Infrared Spectroscopy and Intravascular Ultrasound-Guided vs. Angiography-Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The NIRVUS Trial

TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study)

TCT 192: Beta-Blocker Efficacy in Acute Myocardial Infarction: A Machine Learning Approach Using the KAMIR-NIH Dataset

TCT 991: Ticagrelor Versus Clopidogrel in Cancer Patients With Acute Myocardial Infarction

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content